Endologix Inc (ELGX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Endologix Inc  (ELGX)

Endologix Inc

Officers & Directors


1. John McDermott - Former CEO and President of Endologix. He has over 30 years of executive leadership experience in the medical device industry, having previously served as CEO of FoxHollow Technologies, and as an executive for various companies including Boston Scientific and Johnson & Johnson.

2. Daniel Lemaitre - Former Chairman of the Board of Endologix. He has over 30 years of experience in the medical device industry, having previously served as CEO of CoreValve and as an executive for other companies including Guidant and Medtronic.

3. Vaseem Mahboob - Former Chief Financial Officer of Endologix. He has over 20 years of experience in finance and accounting, having previously held senior finance positions at a variety of companies including Deloitte, Quest Diagnostics, and CareFusion.

4. Todd Abraham - Former Chief Technology Officer of Endologix. He has over 20 years of experience in medical device research and development, having previously held senior leadership positions at St. Jude Medical and Boston Scientific.

5. Greg Morrow - Former Director of Endologix. He has over 30 years of experience in the healthcare industry, having worked as an executive for various companies including Medtronic, Baxter Healthcare, and Cardinal Health.



Endologix Inc currently has 485 employees.






ELGX Management Effectiveness ELGX Revenue per Employee ELGX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.